It depends on what you're trying to do. If you're just storing user data, then SQL is fine. But if you need to store a lot of information about each user, like their posts or comments and the corresponding metadata (like who they're replying to), then NoSQL databases are better because they're optimized for that kind of structure.
I think that Taku-App is a good idea and I would like to try it out.
The problem is that there are too many options for people to choose from. You have to go through the whole process of signing up for an account, which can be time-consuming for some people.
My solution would be to make it easier for people to sign up, so they don't have to go through all of that trouble.
This is a big win for Google, who has been fighting an EU ruling that said it used its Android mobile operating system to stymie rivals. The ruling was upheld by the European Court of Justice on Thursday.
There is no ambiguity. This has happened to me with several accounts I've helped manage. When an account has a history of low CTR, the CPC increases. Starting a new campaign does not help; the CPC remains high until the CTR improves. And it's not cheap.
Many researchers have tried for many years to find a drug for cancer, but I believe no one has succeeded. They treat only early-stage cancer patients who are surviving, but many patients who are not diagnosed in the early stages are not surviving. I hope this is useful for all patients at all stages. Thank you, God and researchers.
Stopping the metastatic surge cancer cells undergo, forming new tumor micro-environments (TME, angiogenesis), are probably the main areas research should focus on to radically boost long-term survival. We need to move cancer from a fatal condition to a chronic condition.
We're sloooowly getting there with antibody drug conjugates like pembrolizumab (https://en.wikipedia.org/wiki/Pembrolizumab), but what truly causes metastatic spread (epithelial–mesenchymal transition) is still a mystery!
I know of at least one patient for stage 4 metastatic melanoma who's been in complete remission for several months on a cocktail of two different immunotherapies. Neither "stage 4" nor "metastatic" suggest early stages.
further context: https://news.ycombinator.com/item?id=32801359, and see also the other two-letter domains on the front page of HN today. i'm not really sure if this is what you were asking, but it at least explains what's going on to somebody from the future who finds their way back to this comment section.
It's a great idea, and it seems like they've put a lot of thought into it. I think it's great that they're focusing on women in the UK, too.